Business Context and Reporting Period
This Form 6-K filing by SIMPPLE LTD. covers the month of March 2026, specifically reporting on a material definitive agreement entered into on March 31, 2026. The Company, a foreign private issuer based in Singapore, is conducting an underwritten public offering of ordinary shares.
Key Financial Metrics and Transaction Details
- Offering Size: 4,000,000 ordinary shares.
- Offering Price: $1.25 per share.
- Underwriter: Network 1 Financial Securities, Inc.
- Underwriter's Warrant: Granted for up to 300,000 ordinary shares at an exercise price of 125% of the offering price ($1.5625).
- Warrant Terms: Exercisable immediately after issuance; expires five years after the closing date; may be exercised on a cashless basis under specific conditions.
- Use of Proceeds: Net proceeds will be used for working capital and general corporate and administrative purposes.
Note: The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes
The primary material change reported is the execution of the Underwriting Agreement for the public offering. This transaction represents a significant capital raise event and the issuance of new equity securities and warrants, altering the Company's capital structure upon closing.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to utilize the net proceeds from the offering to fund working capital and general corporate needs. The offering was made pursuant to an effective shelf registration statement (File No. 333-291085) filed in October 2026 (as stated in the text, though chronologically inconsistent with the March 2026 filing date) and became effective in November 2025.
Risks and Contingencies: The Underwriting Agreement includes customary representations, warranties, indemnification obligations, and termination provisions. The validity of the securities is subject to the legal opinion filed as Exhibit 5.1.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received from the offering.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific indemnification clauses and termination rights.
- Confirm the exact exercise price and cashless exercise mechanics of the Underwriter's Warrant (Exhibit 4.1).
- Check for any subsequent filings regarding the utilization of proceeds or changes in the Company's capital structure.
- Clarify the timeline discrepancy in the text regarding the shelf registration statement filing date (October 2026) versus the filing date (March 2026).